申请人:Warner-Lambert Company
公开号:US05177079A1
公开(公告)日:1993-01-05
The present invention is novel compounds which are 2-substituted-4,6-di-tertiarybutyl-5-hydroxy-1,3-pyrimidines and pharmaceutically acceptable acid addition or base salts thereof, pharmaceutical compositions and methods of use therefor. The invention compounds are now found to have activity as inhibitors of 5-lipoxygenease and/or cyclooxygenase providing treatment of conditions advantageously affected by such inhibition including inflammation, arthritis, pain, fever and the like. Thus, the present invention is also a pharmaceutical composition or method of manufacturing a pharmaceutical composition for the use of treating the noted conditions.
本发明涉及新颖化合物,即2-取代-4,6-二叔丁基-5-羟基-1,3-嘧啶及其药学上可接受的酸盐或碱盐,以及用于其药用组合物和使用方法。发明化合物现已发现具有作为5-脂氧合酶和/或环氧合酶抑制剂的活性,可用于治疗受到此类抑制有利影响的病症,包括炎症、关节炎、疼痛、发热等。因此,本发明还涉及一种用于治疗上述病症的药物组合物或制备药物组合物的方法。